3D printing wire material of artificial bone repair body and application of 3D printing wire material

Through the composite material of polycaprolactone and magnesium-containing tricalcium phosphate powder, the degradation performance, mechanical strength and biological activity of 3D printed artificial bone materials are solved, and excellent biocompatibility and new bone formation are achieved. Avoid the residual cytotoxicity of organic solvents.

CN119034003APending Publication Date: 2024-11-29CHANGZHOU BONE-RENEWAL MEDICAL TECHNOLOGIES LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411253856.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-09-18
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The existing 3D printed artificial bone materials have shortcomings in terms of mechanical properties and biological functions, especially the problems of poor degradation performance and the residual organic solvents leading to cytotoxicity, mechanical strength and biological activity.

Method used

Porous tricalcium phosphate powder is prepared by low temperature wet chemical precipitation method, and solvent residue is avoided by mechanical mixing method to improve the mechanical strength of the material and Biological activity.

Benefits of technology

The excellent degradation performance, mechanical properties and biological activity of artificial bone restorations are achieved, the cytotoxicity problem is avoided, and the growth and vascularization of new bones are promoted.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119034003A_ABST
    Figure CN119034003A_ABST
Patent Text Reader

Abstract

The invention discloses a 3D printing wire material of an artificial bone prosthesis and application of the 3D printing wire material. The wire material is prepared from polycaprolactone and a magnesium-containing tricalcium phosphate powder material which are uniformly mixed, the content of magnesium-containing tricalcium phosphate in the wire material is 10-50wt%, the magnesium-containing tricalcium phosphate powder material is formed by drying a precipitate obtained by mixing and reacting a plurality of salt solutions, and the salt solutions comprise calcium salt, magnesium salt and phosphate solutions. The artificial bone repair body prepared from the 3D printing wire material has excellent degradation performance, mechanical strength and biological activity, and the problem of cytotoxicity caused by organic solvent residues is avoided.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional of the invention with application number CN202311200725.0 filed on September 18, 2023. Technical Field

[0002] The invention relates to a 3D printing filament for an artificial bone repair body and application thereof, in particular to a polycaprolactone / magnesium-containing tricalcium phosphate composite filament. Background Art

[0003] Tumors, trauma, necrosis, congenital malformations and other causes often lead to large-volume bone structure destruction and bone defects. It is urgent to develop new artificial bone materials for bone defect repair. The pore structure of artificial bone materials has a crucial influence on their mechanical properties and biological functions. If the porosity is too high, the mechanical strength is generally low, and if the porosity is too low, it will hinder the growth of new bone tissue. In order to ensure the growth of bone tissue, the pore size is generally greater than 100 microns, and the pores should be interconnected. The traditional manufacturing process of artificial bone materials has low precision, and the use of traditional pore-forming agents cannot obtain special pore structures, which is not conducive to the growth of new bone and angiogenesis. 3D printing technology constructs objects by printing layer by layer. The product has high precision, high material utilization, and can construct complex pore structures. Its application in the field of orthopedics is significantly advanced.

[0004] At present, the 3D printing materials used for biomedical applications are mainly polyetheretherketone and polylactic acid materials. Polyetheretherketone materials are processed and formed by laser melting, and have the characteristics of high mechanical strength and good chemical inertness. They are widely used in fields such as skull printing. However, polyetheretherketone is difficult to degrade in the body and has poor biological activity. See reference 1: Singh S., PrakashC.and et al. Plasma treatment of polyether-ether-ketone: A means of obtaining desirable biomedical characteristics. Eur.Polym.J.2019,118:561-577. Polylactic acid materials are formed by fused deposition molding by stacking filamentary materials layer by layer. This molding method has high printing precision, low cost and strong repeatability, and the obtained polylactic acid scaffold has high mechanical strength. However, the degradation products of polylactic acid are acidic, which is not conducive to the growth of new bone, and the toughness is poor, see reference 2: Lipsa R., Tudorachi N. and et al. Biodegradation of poly (lactic acid) and some of its based systems with Trichoderma viride. Int. J. Biol. Macromol. 2016, 88: 515-526. Researchers have added calcium phosphate materials such as hydroxyapatite to the printing materials to improve the biocompatibility of artificial bone scaffolds, but they still have problems such as non-degradability in the body or the mismatch between the degradation rate and the osteogenesis cycle, and low biological activity, which makes it difficult to meet the growing market demand, see reference 3: Pan Y., Chen Y. and et al. Effect of notch sensitivity on the mechanical properties of HA / PEEK functional gradient biocomposites. J. Polym. Eng. 2016, 36: 933-941. Studies have shown that the degradation cycle of hydroxyapatite can reach more than ten years. After implantation, dense hydroxyapatite material only forms new bone tissue on the surface and lacks the ability to induce bone formation.

[0005] Therefore, there is an urgent need to develop 3D printed composite artificial bone materials with higher bioactivity and full in vivo degradation. Summary of the invention

[0006] The purpose of the present invention is to provide a 3D printing filament for an artificial bone prosthesis and its application. The artificial bone prosthesis printed by the filament has excellent degradation performance, mechanical strength and biological activity, and avoids the cytotoxicity problem caused by organic solvent residues.

[0007] One aspect of the present invention provides a 3D printing filament for an artificial bone repair body, wherein the filament is made of a uniformly mixed polycaprolactone and a magnesium-containing tricalcium phosphate powder material, wherein the content of magnesium-containing tricalcium phosphate in the filament is 10 to 50 wt %, and the magnesium-containing tricalcium phosphate powder material is formed by drying a precipitate obtained after a mixed reaction of multiple salt solutions, wherein the salt solution includes a calcium salt, a magnesium salt and a phosphate solution.

[0008] In a preferred embodiment, the magnesium-containing tricalcium phosphate powder material is formed by spray-drying the precipitate, and has a particle size of 1 to 20 μm.

[0009] In a preferred embodiment, the magnesium-containing tricalcium phosphate powder material contains 1-3% by mass of magnesium.

[0010] In a preferred embodiment, the wire diameter of the wire material is 0.1-0.8 mm.

[0011] In a preferred embodiment, the filament is made by a screw extruder, the temperature of the screw extruder is set at 60-130° C., and the filament making speed is 0.1-5 m / min.

[0012] In a preferred embodiment, polycaprolactone and magnesium-containing tricalcium phosphate powder material are mixed by the following steps: polycaprolactone and magnesium-containing tricalcium phosphate powder material are added to an internal mixer and heated and mixed, the heating temperature is 30-200° C., and the mixing time is 0.5-12 hours; the obtained mixed material is put into a pelletizer and crushed to form a granular material with a diameter of 0.1-10 mm; then the mixed material is added to the internal mixer and mixed again, the heating temperature is 50-150° C., and the mixing time is 0.5-12 hours to obtain a uniformly mixed polycaprolactone / magnesium-containing tricalcium phosphate powder material composite material.

[0013] In a preferred embodiment, the molecular weight of polycaprolactone is 50,000-200,000 Da.

[0014] In a preferred embodiment, the magnesium-containing tricalcium phosphate powder material is prepared by the following steps:

[0015] A first solution is prepared, wherein the first solution contains calcium ions and magnesium ions, and the molar ratio of calcium ions to magnesium ions is 6 to 10; a phosphate solution is prepared, and the pH value is adjusted to 9.5 to 10.5 with an alkali solution to serve as a second solution;

[0016] The first solution and the second solution are heated and mixed, the molar ratio of calcium ions to phosphate ions is 1.1 to 1.5, and reacted at 60 to 95° C. under stirring;

[0017] The suspension obtained after the reaction is centrifuged to obtain a precipitate, which is then washed and spray-dried to obtain the magnesium-containing tricalcium phosphate powder material.

[0018] In a preferred embodiment, the calcium salt is a combination of one or more of anhydrous calcium chloride, calcium chloride dihydrate and calcium nitrate tetrahydrate, the magnesium salt is selected from magnesium chloride hexahydrate and / or magnesium nitrate hexahydrate, the phosphate is selected from a combination of multiple of disodium hydrogen phosphate, diammonium hydrogen phosphate and sodium hydrogen phosphate, and the alkali solution is ammonia water or sodium hydroxide; the cleaned precipitate is spray dried using a spray dryer, the inlet temperature of the spray dryer is 240-300°C, the outlet temperature is 120-150°C, and the feed rate is 30-200mL / min.

[0019] A use of the 3D printing filament in preparing an artificial bone prosthesis by 3D printing.

[0020] The present invention also relates to a method for preparing an artificial bone prosthesis based on 3D printing, comprising the following steps:

[0021] (1) uniformly mixing polycaprolactone and porous tricalcium phosphate powder material;

[0022] (2) preparing the mixed material into a solid printing material;

[0023] (3) According to a preset model, the solid printing material is melt-printed by a 3D printer to produce an artificial bone prosthesis;

[0024] The porous tricalcium phosphate powder material is formed by drying a precipitate obtained after a mixed reaction of a salt solution, wherein the salt solution includes a calcium salt and a phosphate solution.

[0025] In a preferred embodiment, in step (1), the polycaprolactone and porous tricalcium phosphate powder material are mixed uniformly by a mechanical method or a solvent dissolution method.

[0026] In a more preferred embodiment, polycaprolactone and porous tricalcium phosphate powder materials are added to an internal mixer and heated and mixed, the obtained mixed material is put into a pelletizer for crushing, and then added to the internal mixer for uniform mixing again.

[0027] Furthermore, step (1) is specifically implemented as follows: polycaprolactone and porous tricalcium phosphate powder materials are added to an internal mixer and heated and mixed, the heating temperature is 30 to 200° C., and the mixing time is 0.5 to 12 hours; the obtained mixed material is placed in a pelletizer and crushed to form a granular material with a diameter of 0.1 to 10 mm; then the material is added to the internal mixer and mixed again, the heating temperature is 50 to 150° C., and the mixing time is 0.5 to 12 hours to obtain a uniformly mixed polycaprolactone / porous tricalcium phosphate powder material composite material.

[0028] In a more preferred embodiment, step (1) is specifically implemented as follows: polycaprolactone and porous tricalcium phosphate powder materials are dissolved in solvents respectively, stirred and mixed, and then injected into pure water; the precipitated precipitate is collected by filtration, and dried for 6 to 24 hours to obtain a uniformly mixed polycaprolactone / porous tricalcium phosphate powder material composite fiber.

[0029] Furthermore, the solvent includes a combination of one or more of N,N-dimethylformamide (DMF), chloroform, acetone, toluene and carbon tetrachloride, the mass ratio of the solid material to the solvent is 0.01 to 0.2, the volume ratio of the mixed solvent to pure water is 0.05 to 0.2, and the drying temperature is 30 to 100°C.

[0030] In a preferred embodiment, the molecular weight of polycaprolactone is 50,000-200,000 Da.

[0031] In a preferred embodiment, the mass content of the porous tricalcium phosphate powder material in the material after mixing in step (1) is less than 50%; more preferably 10-50%; further 10-40%; further 25-40%. Optionally, the mass content of the porous tricalcium phosphate powder material in the material after mixing is 10%, 15%, 20%, 25%, 30%, 40%, 45%, 50%.

[0032] In a preferred embodiment, in step (2), the solid printing material is a filament, and the filament is made by a screw extruder, the temperature of the screw extruder is set to 60-130° C., and the filament making speed is 0.1-5 m / min.

[0033] In a preferred embodiment, in step (3), the parameters of the 3D printer are set as follows: printing temperature 120-250° C., printing speed 5-70 mm / s, filling rate 20-100%, and wire width 0.1-0.8 mm.

[0034] In a preferred embodiment, the salt solution further comprises magnesium salt, and the porous tricalcium phosphate powder material contains 1-3% by mass of magnesium. More preferably, the mass percentage of magnesium is 1.3-2%. Optionally, the mass percentage of magnesium is 1%, 1.1%, 1.2%, 1.3%, 1.4%, 1.5%, 1.7%, 1.9%, 2%, 2.2%, 2.5%, 2.8% or 3%.

[0035] In a preferred embodiment, the porous tricalcium phosphate powder material is prepared by the following steps:

[0036] Prepare a first solution, wherein the first solution contains calcium ions; prepare a phosphate solution and adjust the pH to 9.5-10.5 with an alkali solution as a second solution;

[0037] The first solution and the second solution are heated and mixed, and reacted at 60 to 95° C. under stirring conditions;

[0038] The suspension obtained after the reaction is centrifuged to obtain a precipitate, which is then washed and spray-dried to obtain the porous tricalcium phosphate powder material.

[0039] In a more preferred embodiment, the first solution further contains magnesium ions, and the molar ratio of calcium ions to magnesium ions in the first solution is 6-10; after the first solution and the second solution are mixed, the molar ratio of calcium ions to phosphate ions is 1.1-1.5; the calcium salt is selected from a combination of one or more of anhydrous calcium chloride, calcium chloride dihydrate and calcium nitrate tetrahydrate, the magnesium salt is selected from magnesium chloride hexahydrate and / or magnesium nitrate hexahydrate, the phosphate is selected from a combination of multiple of disodium hydrogen phosphate, diammonium hydrogen phosphate and sodium hydrogen phosphate, and the alkali solution is ammonia water or sodium hydroxide.

[0040] In a more preferred embodiment, the washed precipitate is spray dried using a spray dryer, wherein the inlet air temperature of the spray dryer is 240-300° C., the outlet air temperature is 120-150° C., and the feed rate is 30-200 mL / min.

[0041] According to a second aspect of the present invention, there is provided an artificial bone prosthesis based on 3D printing, which is prepared by the preparation method described above.

[0042] In a preferred embodiment, the porosity of the artificial bone repair body is 30-70%, the maximum pore size is greater than 300 μm, and the mechanical strength is 2-20 MPa.

[0043] Due to the application of the above technical solution, the present invention has the following advantages compared with the prior art:

[0044] In the artificial bone repair body based on 3D printing and the preparation method thereof of the present invention, a special porous tricalcium phosphate powder material is compounded into a degradable polycaprolactone material to obtain a solid printing filament, and then the artificial bone repair body is melt-printed by a 3D printer. The artificial bone repair body has excellent degradation performance, mechanical properties and biological activity, and can especially avoid the cytotoxicity problem of organic solvents. The internal pores formed are interconnected, which is conducive to new bone growth, material transport and vascularization. BRIEF DESCRIPTION OF THE DRAWINGS

[0045] In order to more clearly illustrate the technical solution of the present invention, the accompanying drawings required for use in the description of the embodiments will be briefly introduced below. Obviously, the accompanying drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other accompanying drawings can be obtained based on these accompanying drawings without paying creative work.

[0046] Figure 1 This is the XRD result of the porous tricalcium phosphate powder material prepared in Example 1.

[0047] Figure 2 This is the SEM microscopic morphology of the porous tricalcium phosphate powder material prepared in Example 1.

[0048] Figure 3 This is the EDS energy spectrum of the porous tricalcium phosphate powder material prepared in Example 1.

[0049] Figure 4 This is a photo of the artificial bone prosthesis prepared in Example 1 of the present invention.

[0050] Figure 5 This is a SEM microscopic morphology of the artificial bone repair body prepared in Example 1 of the present invention.

[0051] Figures 6(a) and 6(c) are the microscopic observation results of MC3T3-E1 bone precursor cells cultured with the artificial bone repair body extract prepared in Example 1 after 1 day and 3 days, respectively; Figures 6(b) and 6(d) are the microscopic observation results of MC3T3-E1 bone precursor cells cultured in the blank control group after 1 day and 3 days, respectively. DETAILED DESCRIPTION

[0052] The preferred embodiments of the present invention are described in detail below in conjunction with the accompanying drawings so that the advantages and features of the present invention can be more easily understood by those skilled in the art. It should be noted that the description of these embodiments is used to help understand the present invention, but does not constitute a limitation of the present invention. In addition, the technical features involved in the various embodiments of the present invention described below can be combined with each other as long as they do not conflict with each other.

[0053] For 3D printed products of polycaprolactone and tricalcium phosphate, if the tricalcium phosphate raw material obtained by conventional calcination and grinding is used, that is, it is prepared by calcination at 1200 degrees, and then ground and sieved to obtain a micron-level hard tricalcium phosphate material. This micron-level hard tricalcium phosphate material has poor mixing performance in polycaprolactone, so it can only be obtained by solvent method to mix a low concentration of polycaprolactone and tricalcium phosphate organic solvent solution to obtain a uniform composite material. However, the solvent method has the toxicity problem of solvent residue, which limits its actual clinical application. The chemical composition of composite hydroxyapatite in 3D printed products is the same as that of inorganic components in human bones, which promotes the adhesion and proliferation of osteoblasts and shows good biocompatibility after implantation in the body. However, it degrades slowly in the body. Studies have shown that the degradation cycle of hydroxyapatite can reach more than ten years. After implantation, dense hydroxyapatite material only forms new bone tissue on the surface and lacks the ability to induce bone formation.

[0054] Based on this, the inventors used a low-density porous tricalcium phosphate material obtained by a low-temperature wet chemical precipitation method, and the active magnesium element doped at the same time was beneficial to osteogenesis. The polycaprolactone can be mixed by a solvent method or a mechanical mixing method can be used to prepare a uniform composite material to solve the following problems:

[0055] (1) Poor degradation performance

[0056] The common materials for 3D printed artificial bone repair bodies are mainly polyetheretherketone and polylactic acid. Among them, polyetheretherketone does not degrade in the body and has poor binding with bone tissue. The degradation products of polylactic acid are acidic and easily induce inflammatory reactions. This application uses polycaprolactone and tricalcium phosphate (preferably containing magnesium) to prepare a fully degradable artificial bone repair body product. The degradation products are neutral and conducive to new bone formation.

[0057] (2) Organic solvent residue problem

[0058] If polycaprolactone is dissolved by an organic solvent and mixed with calcium phosphate powder. Although the better fluidity of the solution helps the materials to be mixed more evenly, the solvent cannot be completely removed in subsequent processes such as drying or filtration, resulting in greater cytotoxicity. The raw materials of this application can be completed by a banburying mechanical mixing method to avoid solvent residue.

[0059] (3) Insufficient mechanical strength and biological activity

[0060] Polycaprolactone is dissolved by an organic solvent and mixed with calcium phosphate powder. The solvent components are freeze-dried after 3D printing, resulting in the mechanical strength of the scaffold material being only 1 to 2 MPa, which is not conducive to application in bone tissue. This application improves the mixing performance by using magnesium-containing tricalcium phosphate material, so that the mixing process can be completed by a banburying mechanical mixing method, which significantly improves the mechanical strength and biological activity of the material.

[0061] The 3D printed magnesium tricalcium phosphate polycaprolactone artificial bone repair body and the preparation method thereof proposed by the inventor specifically include the following steps:

[0062] (1) Weigh polycaprolactone and tricalcium phosphate powder materials and mix the two materials evenly.

[0063] (2) The mixed material is passed through a screw extruder to form a filament.

[0064] (3) After importing the digital model and setting the parameters, a hot melt extrusion 3D printer was used to prepare tricalcium phosphate / polycaprolactone artificial bone repair.

[0065] In step (1), the molecular weight of the polycaprolactone material used is 50000-200000Da; the tricalcium phosphate powder material used is prepared by a low-temperature wet chemical method, and the particle size is 1-20 μm; the content of the tricalcium phosphate material in the polycaprolactone / tricalcium phosphate composite material is 0-50wt.%. Furthermore, the tricalcium phosphate powder material contains magnesium, and the magnesium content is 1-3wt.%, preferably 1.3-2wt.%. The content of the tricalcium phosphate material in the polycaprolactone / tricalcium phosphate composite material is preferably 10-50wt.%.

[0066] In step (1), the two materials can be mixed evenly by mechanical mixing. The specific process of mixing the two materials by mechanical mixing is as follows: add polycaprolactone and magnesium-containing tricalcium phosphate powder materials to an internal mixer and heat and mix them. The heating temperature is 30 to 200°C and the mixing time is 0.5 to 12 hours. The obtained mixed material is put into a pelletizer and crushed to form a granular material with a diameter of 0.1 to 10 mm. Then add it to the internal mixer and mix it evenly again. The heating temperature is 50 to 150°C and the mixing time is 0.5 to 12 hours to obtain a uniformly mixed polycaprolactone / magnesium-containing tricalcium phosphate composite material.

[0067] In step (1), the two materials can also be mixed evenly by solvent dissolution method. The specific process of mixing the two materials by solvent dissolution method is as follows: polycaprolactone and magnesium-containing tricalcium phosphate materials are dissolved and stirred respectively by solvent, the two materials are mixed after stirring evenly, and then injected into pure water. The precipitated precipitate is collected by suction filtration, and a uniformly mixed polycaprolactone / magnesium-containing tricalcium phosphate composite fiber is obtained after drying for 6 to 24 hours. Among them, the solvent used includes but is not limited to N, N-dimethylformamide (DMF), chloroform, acetone, toluene and carbon tetrachloride, the mass ratio of solid material to solvent is 0.01 to 0.2, and the volume ratio of solvent to water after mixing is 0.05 to 0.2. The solvent dissolution stirring time is 10 to 60 minutes, and the drying temperature is 30 to 100°C.

[0068] In step (2), the temperature of the screw extruder used is set to 60-130° C., and the wire making speed is 0.1-5 m / min. The content of tricalcium phosphate in the obtained magnesium tricalcium phosphate polycaprolactone composite wire is 10-50 wt.%.

[0069] In step (3), the parameters of the 3D printer are set as follows: printing temperature 120-250° C., printing speed 5-70 mm / s, filling rate 20-100%, and wire width 0.1-0.8 mm.

[0070] The prepared 3D printed polycaprolactone / magnesium-containing tricalcium phosphate artificial bone repair body has a porosity of 30-70%, a maximum pore size greater than 300 μm, and a mechanical strength of 2-20 MPa.

[0071] The above-mentioned magnesium-containing tricalcium phosphate powder material is prepared by the following steps:

[0072] (1) Dissolving a calcium salt and a magnesium salt in water to obtain a first solution, wherein the concentration of the calcium salt is 1 to 100 g / L, and the concentration of the magnesium salt is 0.4 to 40 g / L. Further, the molar ratio of calcium ions to magnesium ions is 6 to 10; the concentration of the calcium salt is more preferably 30 to 100 g / L, further 50 to 100 g / L, further 60 to 90 g / L, particularly 80 to 90 g / L; for example, 80 g / L, 82 g / L, 84 g / L, 86 g / L, 88 g / L or 90 g / L. Optionally, the concentration of the magnesium salt is more preferably 0.4-30 g / L, further 5-30 g / L, further 15-30 g / L, especially 20-30 g / L; for example, 20 g / L, 22 g / L, 24 g / L, 25 g / L, 27 g / L or 29 g / L.

[0073] (2) Dissolve phosphate in water, and use alkali solution (preferably ammonia water or sodium hydroxide) to adjust the pH to 9.5-10.5, further 9.8-10.0, to obtain a second solution, wherein the concentration of phosphate is 1-100 g / L. The concentration of phosphate in the second solution is more preferably 30-100 g / L, further 50-90 g / L, further 70-90 g / L, especially 80-90 g / L; for example, 81 g / L, 83 g / L, 84 g / L, 85 g / L, 87 g / L or 88 g / L. More preferably, ammonia water is used to adjust the pH to 9.8-10.2. The inventors have found that the pH value has an important influence on the preparation of porous magnesium-containing tricalcium phosphate powder. According to the X-ray diffraction results, too high or too low pH value will produce more impurity phases, resulting in the porous magnesium-containing tricalcium phosphate powder containing more calcium hydrogen phosphate impurity phases or hydroxyapatite.

[0074] (3) heating equal volumes of the first solution and the second solution to 60-95° C. and mixing them, and performing a wet chemical reaction at 60-95° C. and normal pressure under stirring conditions, wherein the stirring rate is 100-500 rpm, and the molar ratio of calcium ions to phosphate ions is 1.1-1.5.

[0075] (4) The suspension after the wet chemical reaction is centrifuged to obtain a precipitate, which is centrifugally washed 4 to 8 times with water, and the washed precipitate is added to 5 to 20 times the mass of water, stirred evenly to form a slurry, and the sizing agent is processed into a porous tricalcium phosphate powder using a spray dryer, wherein the inlet air temperature of the spray dryer is 240 to 300° C., the outlet air temperature is 120 to 150° C., and the feed rate is 30 to 200 mL / min.

[0076] The calcium salt is selected from a combination of one or more of anhydrous calcium chloride, calcium chloride dihydrate and calcium nitrate tetrahydrate, the magnesium salt is selected from magnesium chloride hexahydrate and / or magnesium nitrate hexahydrate, and the phosphate is selected from a combination of multiple of one of disodium hydrogen phosphate, diammonium hydrogen phosphate and sodium hydrogen phosphate.

[0077] The porous tricalcium phosphate powder has a porous structure in the microstructure, and the specific content of magnesium in it shows better biological activity, which effectively promotes new bone formation. Compared with hydroxyapatite, the porous tricalcium phosphate powder material has better degradation performance, so it has significant advantages in the application of bone repair materials. Tricalcium phosphate materials usually need to be prepared by high-temperature calcination or solid-phase reaction at more than 1000 degrees, which requires a lot of energy and the product particles are micron-level, with high density and irregular surface. At present, although some manufacturers can stably produce tricalcium phosphate powder raw materials, most of them are calcined by solid-phase reaction method, and the powder is crushed by mechanical grinding, which is expensive, the grains are larger after sintering, and the shape is irregular geometry, and the fluidity is poor in the process of preparing liquid composite materials. The tricalcium phosphate powder of the present application is prepared based on wet chemical reaction, which directly reacts wet chemically at 60-95°C under normal pressure to generate magnesium-containing tricalcium phosphate suspension, and obtains low-density porous magnesium-containing tricalcium phosphate powder by a special molding method of spray drying.

[0078] Example 1: Preparation of porous tricalcium phosphate powder material

[0079] Weighing and dissolving: weigh 900 g of anhydrous calcium chloride and 270 g of magnesium chloride hexahydrate, dissolve in 10 L of water to obtain solution A; weigh 830 g of diammonium hydrogen phosphate, dissolve in 10 L of water, and use ammonia water to adjust the pH value of the solution to 10.0 to obtain solution B.

[0080] Heating and mixing: Heat solution A and solution B to 70°C and mix them, and continue stirring at 100 rpm to form a suspension.

[0081] Wet chemical reaction: The mixed suspension was heated and stirred at 70°C and 100 rpm for 12 hours.

[0082] Centrifugal washing: The suspension after the wet chemical reaction was centrifuged at 2000 rpm for 3 minutes to obtain the precipitate, and water was added and centrifuged for washing 5 times.

[0083] Spray drying: Add the washed precipitate into 10L of water and stir to form a slurry. Set the spray dryer inlet temperature to 250°C and outlet temperature to 120°C, spray dry the slurry at a rate of 50mL / min to obtain a low-density porous tricalcium phosphate powder.

[0084] Test: The XRD results, SEM micromorphology and EDS spectrum of the porous tricalcium phosphate powder are as follows: Figures 1 to 3 , wherein the magnesium content is 1.9% and the particle size distribution is in the range of 5 to 20 μm.

[0085] Example 2: Preparation of artificial bone prosthesis

[0086] Weighing and mixing: 180g of polycaprolactone and 120g of the porous tricalcium phosphate powder material prepared in Example 1 were weighed and added to an internal mixer for mixing, the heating temperature was 100°C, and the mixing time was 1 hour. The obtained mixed material was put into a pelletizer for crushing to form granular materials with a diameter of less than 5mm. Then, it was added to an internal mixer and mixed again, the heating temperature was 100°C, and the mixing time was 1 hour to obtain a uniformly mixed magnesium-containing tricalcium phosphate polycaprolactone composite material.

[0087] Wire making: Using a screw extruder, the feed temperature is set to 90°C and the process temperature is controlled at 100°C. The uniformly mixed magnesium tricalcium phosphate polycaprolactone composite material is added to the twin-screw extruder, the extruded wire diameter is set to 2.85 mm, and the wire making speed is set to 1 m / min to obtain a 3D printing wire material, wherein the magnesium tricalcium phosphate content is 40wt%.

[0088] 3D printing: import the digital model, set the printing temperature to 180°C, the printing speed to 5 mm / s, the filling rate to 80%, and the wire width to 0.4 mm to prepare the 3D printed polycaprolactone / tricalcium phosphate artificial bone prosthesis. Figure 4 shown.

[0089] Detection: The microscopic morphology of 3D printed polycaprolactone / tricalcium phosphate artificial bone repair Figure 5Figures 6 (a) and 6 (c) show the microscopic observation results of 1 day and 3 days of culturing MC3T3-E1 bone progenitor cells with the leaching solution of the 3D printed polycaprolactone / tricalcium phosphate artificial bone prosthesis, respectively; Figures 6 (b) and 6 (d) show the microscopic observation results of 1 day and 3 days of culturing MC3T3-E1 bone progenitor cells with the blank control group, respectively, in which both extraction experiments used DMEM culture medium as the cell culture medium. The cell experiment of the leaching solution showed that the cells grew well, and the obtained artificial bone prosthesis had no cytotoxicity and good biocompatibility.

[0090] Example 3: Preparation of artificial bone repair body

[0091] Weighing and mixing: 240g of polycaprolactone and 60g of magnesium-containing tricalcium phosphate prepared in Example 1 were weighed and added to an internal mixer for mixing, the heating temperature was 100°C, and the mixing time was 1 hour. The obtained mixed material was put into a pelletizer for crushing to form granular materials with a diameter of less than 5mm. Then, it was added to the internal mixer and mixed again, the heating temperature was 80°C, and the mixing time was 1 hour to obtain a uniformly mixed magnesium-containing tricalcium phosphate polycaprolactone composite material.

[0092] Wire making: Using a screw extruder, the feed temperature is set to 80°C and the process temperature is controlled at 90°C. The uniformly mixed magnesium tricalcium phosphate polycaprolactone composite material is added to the twin-screw extruder, the extruded wire diameter is set to 1.75 mm, and the wire making speed is set to 1 m / min to obtain a 3D printing wire material, wherein the magnesium tricalcium phosphate content is 20wt%.

[0093] 3D printing: The digital model was imported, the printing temperature was set to 130°C, the printing speed was 20 mm / s, the filling rate was 30%, and the wire width was 0.4 mm to prepare a 3D printed magnesium tricalcium phosphate polycaprolactone artificial bone. After the extract cell experiment, the cells grew well, and it had the same biocompatibility as the artificial bone prosthesis of Example 2, without cytotoxicity.

[0094] Example 4: Preparation of artificial bone repair body

[0095] Weighing and dissolving: Weigh 200g of polycaprolactone and dissolve it in 4.0kg of DMF reagent, and stir it with a stirring paddle at 400rpm for 30min until the solution is uniform. Weigh 20g of the porous magnesium-containing tricalcium phosphate powder material prepared in Example 1 and dissolve it in 4.0kg of DMF reagent, and stir it with a stirring paddle at 400rpm for 30min until the solution is uniform.

[0096] Mixing configuration: Mix the solution of magnesium tricalcium phosphate and polycaprolactone, stir with a stirring paddle at 400 rpm for 30 minutes until the solution is uniform, then inject into 100L pure water, and a white flocculent precipitate will appear. Use a vacuum filter to filter to obtain polycaprolactone magnesium tricalcium phosphate composite fiber, and dry it in an oven at 60°C for 12 hours.

[0097] Wire making: Use a screw extruder, set the feed temperature to 90°C, and control the process temperature to 100°C. Add the dried magnesium-containing tricalcium phosphate and polycaprolactone composite into the screw extruder, set the extruded wire diameter to 1.75 mm, and set the wire making speed to 1 m / min to obtain filaments for 3D printing.

[0098] 3D printing: The digital model was imported, the printing temperature was set to 150°C, the printing speed was 10 mm / s, the filling rate was 50%, and the wire width was 0.4 mm to prepare a 3D printed magnesium tricalcium phosphate polycaprolactone artificial bone. After the extract cell experiment, the cells grew well, and it had the same biocompatibility as the artificial bone prosthesis in Example 2, without cytotoxicity.

[0099] The above-mentioned artificial bone prosthesis based on 3D printing has the following characteristics:

[0100] (1) Connected pore structure

[0101] Complex interconnected pore structures are manufactured through hot-melt 3D printing technology. The material is flexible and the composite material design overcomes the problems of traditional ceramic materials, such as high brittleness and difficulty in processing. Compared with existing bone filling materials, the artificial bone repair material of this application can be individually customized and is easy to cut and process, which is convenient for doctors to shape during surgery. 3D printed porous artificial bones promote the adhesion of osteoblasts and the deposition of bone tissue, and improve bone conductivity and bioactivity. The interconnected pores inside the 3D printed porous scaffold are conducive to new bone growth, material transport and vascularization.

[0102] (2) Degradation performance

[0103] The degradation products of polycaprolactone are neutral and not easy to induce inflammatory response. At the same time, when polycaprolactone is directly used for bone tissue repair, the biological activity is insufficient, and the new bone tissue cannot form a tight bone bond with the polymer scaffold. This application uses tricalcium phosphate material to composite polycaprolactone. Compared with traditional hydroxyapatite materials, tricalcium phosphate (β-TCP) has a similar chemical composition, but has better degradation performance. It can produce biologically active ions Ca through degradation. 2+ and PO4 3- Ions. After being implanted in the body, tricalcium phosphate ceramics can form a strong chemical bond with bones.

[0104] (3) The internal mixing method has no solvent residue problem

[0105] The porous magnesium-containing tricalcium phosphate powder material of the present application has better fluidity in molten polycaprolactone. The porous magnesium-containing tricalcium phosphate powder material and polycaprolactone are mixed by a banburying mechanical mixing method, which improves the mixing performance, so that the mixing process can be completed by the banburying mechanical mixing method without adding organic solvents, thereby avoiding the cytotoxicity caused by organic reagents.

[0106] (4) Insufficient mechanical strength and biological activity

[0107] By adopting porous magnesium-containing tricalcium phosphate powder material, the mixing performance is improved, and the mixing process can be completed by a mixing mechanical mixing method, which significantly improves the mechanical strength and biological activity of the material.

[0108] In addition, the use of porous magnesium-containing tricalcium phosphate powder material as the main raw material has better biological activity than traditional calcium phosphate materials. The magnesium ions doped in the magnesium-containing tricalcium phosphate material can induce osteoblast differentiation and osteogenic expression after degradation and release in vivo.

[0109] As shown in this specification and claims, the terms "comprises" and "include" only indicate the inclusion of the steps and elements that have been clearly identified, and these steps and elements do not constitute an exclusive list, and the method or device may also include other steps or elements. The term "and / or" as used herein includes any combination of one or more of the relevant listed items.

[0110] The endpoints and any values ​​of the ranges disclosed in this article are not limited to the precise ranges or values, and these ranges or values ​​should be understood to include values ​​close to these ranges or values. For numerical ranges, the endpoint values ​​of each range, the endpoint values ​​of each range and the individual point values, and the individual point values ​​can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed in this article.

[0111] Unless otherwise defined, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art. If there is any conflict or inconsistency between the definitions used herein and the definitions contained in other public documents, the definitions used herein shall prevail.

[0112] The above embodiment is only for illustrating the technical concept and features of the present invention, and is a preferred embodiment. Its purpose is to enable people familiar with the technology to understand the content of the present invention and implement it accordingly, and it cannot be used to limit the protection scope of the present invention. Any equivalent transformation or modification made according to the principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A 3D printing filament for an artificial bone repair body, characterized in that: The wire material is made of a uniformly mixed polycaprolactone and a magnesium-containing tricalcium phosphate powder material, the content of magnesium-containing tricalcium phosphate in the wire material is 10-50wt%, and the magnesium-containing tricalcium phosphate powder material is formed by drying a precipitate after a mixed reaction of multiple salt solutions, and the salt solution includes a calcium salt, a magnesium salt and a phosphate solution.

2. The 3D printing filament according to claim 1, characterized in that: The magnesium-containing tricalcium phosphate powder material is formed by spray-drying the precipitate, and has a particle size of 1 to 20 μm.

3. The 3D printing filament according to claim 1, characterized in that: The magnesium-containing tricalcium phosphate powder material contains 1-3% by mass of magnesium element.

4. The 3D printing filament according to claim 1, characterized in that: The wire diameter of the wire material is 0.1-0.8 mm.

5. The 3D printing filament according to claim 1, characterized in that: The wire material is made by a screw extruder, the temperature of the screw extruder is set at 60-130° C., and the wire making speed is 0.1-5 m / min.

6. The 3D printing filament according to claim 1, characterized in that: The polycaprolactone and magnesium-containing tricalcium phosphate powder materials are mixed uniformly through the following steps: the polycaprolactone and magnesium-containing tricalcium phosphate powder materials are added to an internal mixer for heating and mixing, the heating temperature is 30-200°C, and the mixing time is 0.5-12 hours; the obtained mixed material is put into a pelletizer for crushing to form a granular material with a diameter of 0.1-10 mm; and then the mixed material is added to the internal mixer for uniform mixing again, the heating temperature is 50-150°C, and the mixing time is 0.5-12 hours, so as to obtain a uniformly mixed polycaprolactone / magnesium-containing tricalcium phosphate powder material composite material.

7. The 3D printing filament according to claim 1, characterized in that: The molecular weight of polycaprolactone is 50,000 to 200,000 Da.

8. The 3D printing filament according to claim 1, characterized in that: The magnesium-containing tricalcium phosphate powder material is prepared by the following steps: A first solution is prepared, wherein the first solution contains calcium ions and magnesium ions, and the molar ratio of calcium ions to magnesium ions is 6 to 10; a phosphate solution is prepared, and the pH value is adjusted to 9.5 to 10.5 with an alkali solution to serve as a second solution; The first solution and the second solution are heated and mixed, the molar ratio of calcium ions to phosphate ions is 1.1 to 1.5, and reacted at 60 to 95° C. under stirring; The suspension obtained after the reaction is centrifuged to obtain a precipitate, which is then washed and spray-dried to obtain the magnesium-containing tricalcium phosphate powder material.

9. The 3D printing filament according to any one of claims 1 to 8, characterized in that: The calcium salt is selected from a combination of one or more of anhydrous calcium chloride, calcium chloride dihydrate and calcium nitrate tetrahydrate, the magnesium salt is selected from magnesium chloride hexahydrate and / or magnesium nitrate hexahydrate, the phosphate is selected from a combination of one or more of disodium hydrogen phosphate, diammonium hydrogen phosphate and sodium hydrogen phosphate, and the alkali solution is ammonia water or sodium hydroxide; a spray dryer is used to spray dry the washed precipitate, the inlet air temperature of the spray dryer is 240-300°C, the outlet air temperature is 120-150°C, and the feed rate is 30-200mL / min.

10. Use of the 3D printing filament according to any one of claims 1 to 9 in preparing an artificial bone repair body by 3D printing.